A Positive Diagnostic Strategy Is Noninferior to a Strategy of Exclusion for Patients With Irritable Bowel Syndrome Luise M. Begtrup, Anne Line Engsbro, Jens Kjeldsen, Pia V. Larsen, Ove Schaffalitzky de Muckadell, Peter Bytzer, Dorte E. Jarbøl Clinical Gastroenterology and Hepatology Volume 11, Issue 8, Pages 956-962.e1 (August 2013) DOI: 10.1016/j.cgh.2012.12.038 Copyright © 2013 AGA Institute Terms and Conditions
Figure 1 Differences between the 2 groups in the change from baseline to 1 year on the PCS of the SF-36 with two-sided 95% confidence interval (Positive strategy — strategy of exclusion). Clinical Gastroenterology and Hepatology 2013 11, 956-962.e1DOI: (10.1016/j.cgh.2012.12.038) Copyright © 2013 AGA Institute Terms and Conditions
Trial profile (Consort style). Clinical Gastroenterology and Hepatology 2013 11, 956-962.e1DOI: (10.1016/j.cgh.2012.12.038) Copyright © 2013 AGA Institute Terms and Conditions